EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptomic and functional responses of the cystic fibrosis airway epithelium to CFTR modulator therapy

Eszter K Vladar, Austin E Gillen, Sangya Yadav, Mikayla R Murphree, David Baraghoshi, J Kirk Harris, Elmar Pruesse, Sierra S Niemiec, Alexandra Wm Wilson, Katherine B Hisert, Stephen M Humphries, Matthew Strand und 4 weitere

JCI Insight · 2025

DOI: 10.1172/jci.insight.196018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, 2025. Verfasst von Eszter K Vladar und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Colorado, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Quinolones, Aminophenols. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Cystic Fibrosis Foundation, Marshall and Margherite McComb Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elexacaftor/tezacaftor/ivacaftor (ETI) cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy has led to rapid and substantial improvements in cystic fibrosis (CF) airway disease. Underlying molecular and cellular mechanisms, long-term efficacy, and ability to reverse airway epithelial remodeling in established disease remain unclear. Longitudinal nasal brushes from an adult CF cohort were used to evaluate gene expression, cellular composition, stem cell function, and microbiome changes at baseline and at 6 months and 2 years after ETI. The baseline to 6 month span showed a massive downregulation of extensive neutrophilic inflammatory gene expression programs that correlated with increased pulmonary function and decreased sinusitis. Primary airway epithelial stem cell cultures from matched donor samples showed partially improved differentiation and barrier capacity at 6 months. Although clinical outcomes remained stable during the 6 month to 2 year span, transcriptional changes revealed a resurgence of baseline inflammatory programs. The time course of gene expression was consistent with ongoing normalization of epithelial remodeling. Relative abundance of Pseudomonas also decreased during the time course. These data suggest that ETI rectifies inflammation, epithelial remodeling, and bacterial infection in the airways, but resurgence of inflammatory gene expression may indicate ongoing inflammation, potentially presaging disease progression with long-term therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorQuinolonesAminophenolsBenzodioxolesTranscriptomeRespiratory MucosaIndolesPyridinesHumansAdultFemaleMaleDrug CombinationsPyrazolesYoung AdultPyrrolidinesAirway RemodelingChloride Channel AgonistsTreatment OutcomeQuinolines

Stichwörter der Autor:innen

Cellular immune responseInflammationMonogenic diseasesPulmonologyTranscriptomics

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorQuinolonesAminophenolsBenzodioxolesCFTR protein, humanIndolesDrug CombinationsPyridinesPyrazolesPyrrolidines

Autor:innen und Institutionen

  • Department of Medicine, University of Colorado, Aurora, Colorado, USA.
  • Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado, USA.
  • Division of Biostatistics, National Jewish Health, Denver, Colorado, USA.
  • Departments of Pediatrics, University of Colorado, Aurora, Colorado, USA.
  • Center for Genes, Environment, and Health, and.
  • Department of Pediatrics, National Jewish Health, Denver, Colorado, USA.

Förderung

  • NHLBI NIH HHS
  • Cystic Fibrosis Foundation
  • Marshall and Margherite McComb Foundation

Zitieren

APA

Vladar, E. K., Gillen, A. E., Yadav, S., Murphree, M. R., Baraghoshi, D., Harris, J. K., Pruesse, E., Niemiec, S. S., Wilson, A. W., Hisert, K. B., Humphries, S. M., Strand, M., Lynch, D. A., Seibold, M. A., Beswick, D. M., & Taylor-Cousar, J. L. (2025). Transcriptomic and functional responses of the cystic fibrosis airway epithelium to CFTR modulator therapy. JCI Insight. https://doi.org/10.1172/jci.insight.196018

Vancouver

Vladar EK, Gillen AE, Yadav S, Murphree MR, Baraghoshi D, Harris JK, et al. Transcriptomic and functional responses of the cystic fibrosis airway epithelium to CFTR modulator therapy. JCI Insight. 2025. doi:10.1172/jci.insight.196018

BibTeX
@article{Vladar2025,
  author = {Vladar, Eszter K and Gillen, Austin E and Yadav, Sangya and Murphree, Mikayla R and Baraghoshi, David and Harris, J Kirk and Pruesse, Elmar and Niemiec, Sierra S and Wilson, Alexandra Wm and Hisert, Katherine B and Humphries, Stephen M and Strand, Matthew and Lynch, David A and Seibold, Max A and Beswick, Daniel M and Taylor-Cousar, Jennifer L},
  title = {Transcriptomic and functional responses of the cystic fibrosis airway epithelium to CFTR modulator therapy},
  journal = {JCI Insight},
  year = {2025},
  doi = {10.1172/jci.insight.196018}
}
Kostenlos starten →